Jun
2026
Shanghai New International Expo Center
Visit us
stand E3C70b, Pharma Excipients

CRODA

About Us

Founded in the UK in 1925, Croda is dedicated to enhancing biologics delivery capabilities. As a globally renowned ingredients supplier and partner to leading pharmaceutical companies, universities, and research institutes. Croda offers a comprehensive portfolio including high-purity pharmaceutical excipients, vaccine adjuvants, and novel liposomes. These products are widely applied across four core technology platforms: small molecule delivery, protein delivery, vaccine nucleic acid delivery, and vaccine adjuvant systems. • Super Refined™ Polysorbate Series (PS 20/80/80 POA): High-purity excipients utilized in multiple blockbuster innovator monoclonal antibody (mAb) products worldwide and widely adopted in the global biologics market. • Bioprocessing solutions, covering high-purity excipients for upstream, downstream, and final formulations, including Super Refined™ Poloxamer 188, BioXPro high-purity amino acids and hydrochloride salts, Virodex™ series, and high-purity polysorbate. • Vaccine Adjuvants: With over 80 years of research and commercialization experience, offering full-spectrum vaccine adjuvant solutions. The portfolio includes classic aluminum adjuvants, the PHAD® product line (fully synthetic MPLA), squalene (non-animal source), CAF®01/09b. • Avanti Lipids: Leveraging over 50 years of innovative lipid research and commercialization experience to provide 2,000+ research-grade innovative lipid excipients, alongside custom lipid synthesis and CMO services. The GMP-grade lipid portfolio includes DSPC, DOPC, DSPE-PEG2000 Maleimide, and more. Notably, Avanti supplied 4 key LNP lipid excipients for Pfizer's world-first COVID-19 mRNA vaccine in 2020. We are more than just a raw material supplier; we provide comprehensive technical support and robust regulatory services. We assist clients in accelerating drug R&D timelines, shortening time-to-market, tackling disease challenges together, and empowering highly efficient drug delivery. For more information, please visit the Croda China official website: www.crodapharma.cn Follow the us on WeChat: Croda禾大医药健康

  • Country/Region:
    United Kingdom
  • On CPHI since:
    2015
  • Certificates:
    2
  • Employees:
    1000 - 4999
Company types
Manufacturer/Innovator
Primary activities
Animal Health
Custom Manufacturing/Custom Synthesis
Excipients Manufacturer
Fine Chemicals Company
Contact info
Event information
CPHI & PMEC China 2026
  • 16 Jun 2026 - 18 Jun 2026
  • Shanghai New International Expo Center
  • Visit us at stand E3C70b, Pharma Excipients

Products Featured at CPHI & PMEC China 2026

  • Adjuvant Systems for Vaccines

    Product Adjuvant Systems for Vaccines

    We enable next-generation vaccine development through a diverse portfolio of world-leading vaccine adjuvants, immunomodulators and adjuvant formulations.
    We passionately develop new adjuvant technologies and partner to develop the vaccines of tomorrow.
    Our extensive expertise in immunology and fo...
  • Bioprocessing solutions and excipients for protein therapeutic formulations

    Product Bioprocessing solutions and excipients for protein therapeutic formulations

    From excipients for protein therapeutic formulations, to innovating solutions for bioprocessing, we have decades of experience in protein delivery. TALK TO US about our latest launches: Virodex™ detergent range, a sustainable alternative to Triton™ X-100 for viral inactivation and cell lysis. Plus, Tween...
  • Excipients for Consumer Health

    Product Excipients for Consumer Health

    Croda Pharma's Consumer Health offering combines our technical expertise with regulatory knowledge to help our customers market innovative products with consumer relevant claims, alongside supporting formulation development challenges within the Consumer Health market.
    Our excipient solutions support ...
  • High purity excipients for small molecule delivery

    Product High purity excipients for small molecule delivery

    We offer high purity, multi-compendial, pharmaceutical excipients for small molecule drug delivery. Our portfolio of high purity excipient products and speciality chemistries solve formulation challenges and enhance drug delivery across a variety of administration routes and dosage forms. We are market le...
  • Nucleic Acid Delivery for Vaccines and Next-Gen Therapeutics

    Product Nucleic Acid Delivery for Vaccines and Next-Gen Therapeutics

    Avanti Polar Lipids, part of Croda Pharma, develops innovative lipids of unparalleled purity to solve the stability and delivery issues associated with mRNA for use in vaccines and next-generation therapeutics.
    We develop and manufacture highly specialised lipids used in Lipid Nanoparticle (LNP) deliv...

Croda pharma Resources (1)

  • Brochure Addressing the challenges of vaccine formulation

    To this day, our focus has been to successfully develop, manufacture and market high-quality adjuvants for our pharmaceutical customers. This heritage makes our vaccine adjuvants unique in the industry. A heritage we are proud of. 

    Our industry-leading, Alhydrogel®, Adju-Phos® and Quil-A® are widely recognised in the vaccine industry for their unmatched track record when it comes to a proven history of safe and effective use.